首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   186294篇
  免费   11303篇
  国内免费   476篇
耳鼻咽喉   2402篇
儿科学   6028篇
妇产科学   4051篇
基础医学   25581篇
口腔科学   8175篇
临床医学   14251篇
内科学   41329篇
皮肤病学   4681篇
神经病学   15763篇
特种医学   5654篇
外国民族医学   26篇
外科学   22635篇
综合类   1516篇
现状与发展   1篇
一般理论   71篇
预防医学   19373篇
眼科学   3489篇
药学   11288篇
中国医学   734篇
肿瘤学   11025篇
  2023年   962篇
  2022年   893篇
  2021年   4123篇
  2020年   2776篇
  2019年   3989篇
  2018年   5418篇
  2017年   4067篇
  2016年   3808篇
  2015年   4443篇
  2014年   6091篇
  2013年   7763篇
  2012年   12140篇
  2011年   12690篇
  2010年   6441篇
  2009年   5780篇
  2008年   9882篇
  2007年   10429篇
  2006年   9696篇
  2005年   9896篇
  2004年   9279篇
  2003年   8502篇
  2002年   6517篇
  2001年   5057篇
  2000年   5020篇
  1999年   4435篇
  1998年   1720篇
  1997年   1395篇
  1996年   1219篇
  1995年   1160篇
  1994年   1158篇
  1993年   1042篇
  1992年   2696篇
  1991年   2616篇
  1990年   2382篇
  1989年   2361篇
  1988年   2131篇
  1987年   1982篇
  1986年   1864篇
  1985年   1775篇
  1984年   1284篇
  1983年   1040篇
  1982年   613篇
  1981年   540篇
  1980年   526篇
  1979年   941篇
  1978年   612篇
  1977年   484篇
  1975年   554篇
  1974年   546篇
  1973年   550篇
排序方式: 共有10000条查询结果,搜索用时 328 毫秒
1.
2.
3.
4.
5.
6.
We present data from patients with advanced biliary tract cancer (BTC) receiving pembrolizumab in the KEYNOTE-158 (NCT02628067; phase 2) and KEYNOTE-028 (NCT02054806; phase 1b) studies. Eligible patients aged ≥18 years from both studies had histologically/cytologically confirmed incurable BTC that progressed after standard treatment regimen(s), measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1, Eastern Cooperative Oncology Group performance status 0/1, and no prior immunotherapy. Programmed death ligand 1 (PD-L1)-positive tumors were required for eligibility in KEYNOTE-028 only. Patients received pembrolizumab 200 mg every three weeks (KEYNOTE-158) or 10 mg/kg every two weeks (KEYNOTE-028) for ≤2 years. Primary efficacy endpoint was objective response rate (ORR) by RECIST v1.1. Response assessed by independent central review is reported. KEYNOTE-158 enrolled 104 patients and KEYNOTE-028 enrolled 24 patients. Median (range) follow-up was 7.5 months (0.6-34.3) in KEYNOTE-158 and 5.7 months (0.6-55.4) in KEYNOTE-028. In KEYNOTE-158, ORR was 5.8% (6/104; 95% CI, 2.1%-12.1%); median duration of response (DOR) was not reached (NR) (range, 6.2-26.6+ months). Median (95% CI) OS and PFS were 7.4 (5.5-9.6) and 2.0 (1.9-2.1) months. Among PD-L1-expressers (n = 61) and PD-L1-nonexpressers (n = 34), respectively, ORR was 6.6% (4/61) and 2.9% (1/34). In KEYNOTE-028, ORR was 13.0% (3/23; 95% CI, 2.8%-33.6%); median DOR was NR (range, 21.5-53.2+ months). Median (95% CI) OS and PFS were 5.7 (3.1-9.8) and 1.8 (1.4-3.1) months. Grade 3 to 5 treatment-related adverse events occurred in 13.5% of patients in KEYNOTE-158 (no grade 4; grade 5 renal failure, n = 1) and 16.7% in KEYNOTE-028 (no grade 4/5). In summary, pembrolizumab provides durable antitumor activity in 6% to 13% of patients with advanced BTC, regardless of PD-L1 expression, and has manageable toxicity.  相似文献   
7.
8.
Neorickettsia helminthoeca (NH), the agent of salmon poisoning disease or canine neorickettiosis (CN), is a bacterial endosymbiont of the nematode Nanophyetus salmincola, and infections are spreading among specific fish‐eating mammalians. This article describes the pathologic and immunohistochemical findings associated with spontaneous NH‐induced infections in dogs from Southern Brazil. The principal pathologic findings were hypertrophy of Peyer patches and lymphadenopathy with lymphocytic proliferation, chronic interstitial pneumonia, and chronic enteritis associated with positive intralesional immunoreactivity to antigens of NH within macrophages and histiocytes. Positive immunoreactivity against canine parvovirus‐2 (CPV‐2) or/and canine distemper virus was not detected in the evaluated intestinal segments or in the samples from the cerebellum and lungs, respectively, from the dogs evaluated. These findings demonstrated that NH was involved in the enteric, pulmonary, and lymphoid lesions herein described, and provide additional information to confirm the occurrence of this bacterial endosymbiont within this geographical location. It is proposed that chronic pneumonia should be considered as a pathologic manifestation of NH‐induced infections. Additionally, our results show that the occurrences of CN seem to be underdiagnosed in Southern Brazil due to the confusion with the incidence of CPV‐2.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号